Dr. David L. Grinblatt
Claim this profileNorthShore University HealthSystem-Evanston Hospital
Studies Acute Myeloid Leukemia
Studies Lymphoma
5 reported clinical trials
18 drugs studied
Area of expertise
1Acute Myeloid Leukemia
13q positive
13q negative
12 positive
2Lymphoma
13q positive
13q negative
12 positive
Affiliated Hospitals
Clinical Trials David L. Grinblatt is currently running
Blinatumomab + Chemotherapy
for Leukemia
This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus blinatumomab. Blinatumomab is a Bi-specific T-Cell Engager ('BiTE') that may interfere with the ability of cancer cells to grow and spread. The information gained from this study may help researchers determine if combination therapy with steroids, TKIs, and blinatumomab work better than the standard of care.
Recruiting2 awards Phase 310 criteria
Lenalidomide + Dexamethasone +/- Daratumumab
for Multiple Myeloma
This phase III trial studies how well lenalidomide and dexamethasone works with or without daratumumab in treating patients with high-risk smoldering myeloma. Drugs used in chemotherapy, such as lenalidomide and dexamethasone, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as daratumumab, may induce changes in the body's immune system and may interfere with the ability of tumor cells to grow and spread. Giving lenalidomide and dexamethasone with daratumumab may work better in treating patients with smoldering myeloma.
Recruiting2 awards Phase 312 criteria
More about David L. Grinblatt
Clinical Trial Related5 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments David L. Grinblatt has experience with
- Venetoclax
- Obinutuzumab
- Dexamethasone
- Cytarabine
- Ibrutinib
- Daratumumab
Breakdown of trials David L. Grinblatt has run
Acute Myeloid Leukemia
Lymphoma
Chronic Lymphocytic Leukemia
Plasma Cell Neoplasm
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David L. Grinblatt specialize in?
David L. Grinblatt focuses on Acute Myeloid Leukemia and Lymphoma. In particular, much of their work with Acute Myeloid Leukemia has involved 13q positive patients, or patients who are 13q negative.
Is David L. Grinblatt currently recruiting for clinical trials?
Yes, David L. Grinblatt is currently recruiting for 3 clinical trials in Evanston Illinois. If you're interested in participating, you should apply.
Are there any treatments that David L. Grinblatt has studied deeply?
Yes, David L. Grinblatt has studied treatments such as Venetoclax, Obinutuzumab, Dexamethasone.
What is the best way to schedule an appointment with David L. Grinblatt?
Apply for one of the trials that David L. Grinblatt is conducting.
What is the office address of David L. Grinblatt?
The office of David L. Grinblatt is located at: NorthShore University HealthSystem-Evanston Hospital, Evanston, Illinois 60201 United States. This is the address for their practice at the NorthShore University HealthSystem-Evanston Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.